Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study.
Considerations for subgroups and phenocopies in complex disease genetics.
Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Making myelin basic protein -from mRNA transport to localized translation.
The incidence and prevalence of neuromyelitis optica: a systematic review.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Web search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postings.
Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.
Voiding Dysfunction in Multiple Sclerosis.
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
An overview of pregnancy-related issues in patients with multiple sclerosis.
Roche hits multiple sclerosis landmarks.
Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.
Multiple sclerosis and pregnancy: a comparison study.
An acute transverse myelitis attack after total body irradiation: a rare case.
Review of the biology of multiple sclerosis.
Pages
« first
‹ previous
…
657
658
659
660
661
662
663
664
665
…
next ›
last »